S&P 500   4,657.22 (+1.36%)
DOW   35,139.35 (+0.69%)
QQQ   398.68 (+1.91%)
AAPL   160.38 (+2.28%)
MSFT   337.98 (+2.52%)
FB   337.64 (+1.36%)
GOOGL   2,901.19 (+2.02%)
AMZN   3,582.18 (+2.21%)
TSLA   1,132.99 (+4.72%)
NVDA   328.41 (+4.25%)
BABA   131.76 (-1.19%)
NIO   40.01 (+0.05%)
CGC   11.02 (-5.73%)
AMD   158.89 (+2.64%)
GE   97.51 (-0.34%)
MU   84.79 (+1.64%)
T   23.88 (-1.40%)
F   19.73 (-0.10%)
DIS   144.95 (-2.13%)
ACB   6.43 (-5.30%)
AMC   36.47 (-3.08%)
PFE   53.77 (-0.43%)
BA   196.50 (-1.36%)
S&P 500   4,657.22 (+1.36%)
DOW   35,139.35 (+0.69%)
QQQ   398.68 (+1.91%)
AAPL   160.38 (+2.28%)
MSFT   337.98 (+2.52%)
FB   337.64 (+1.36%)
GOOGL   2,901.19 (+2.02%)
AMZN   3,582.18 (+2.21%)
TSLA   1,132.99 (+4.72%)
NVDA   328.41 (+4.25%)
BABA   131.76 (-1.19%)
NIO   40.01 (+0.05%)
CGC   11.02 (-5.73%)
AMD   158.89 (+2.64%)
GE   97.51 (-0.34%)
MU   84.79 (+1.64%)
T   23.88 (-1.40%)
F   19.73 (-0.10%)
DIS   144.95 (-2.13%)
ACB   6.43 (-5.30%)
AMC   36.47 (-3.08%)
PFE   53.77 (-0.43%)
BA   196.50 (-1.36%)
S&P 500   4,657.22 (+1.36%)
DOW   35,139.35 (+0.69%)
QQQ   398.68 (+1.91%)
AAPL   160.38 (+2.28%)
MSFT   337.98 (+2.52%)
FB   337.64 (+1.36%)
GOOGL   2,901.19 (+2.02%)
AMZN   3,582.18 (+2.21%)
TSLA   1,132.99 (+4.72%)
NVDA   328.41 (+4.25%)
BABA   131.76 (-1.19%)
NIO   40.01 (+0.05%)
CGC   11.02 (-5.73%)
AMD   158.89 (+2.64%)
GE   97.51 (-0.34%)
MU   84.79 (+1.64%)
T   23.88 (-1.40%)
F   19.73 (-0.10%)
DIS   144.95 (-2.13%)
ACB   6.43 (-5.30%)
AMC   36.47 (-3.08%)
PFE   53.77 (-0.43%)
BA   196.50 (-1.36%)
S&P 500   4,657.22 (+1.36%)
DOW   35,139.35 (+0.69%)
QQQ   398.68 (+1.91%)
AAPL   160.38 (+2.28%)
MSFT   337.98 (+2.52%)
FB   337.64 (+1.36%)
GOOGL   2,901.19 (+2.02%)
AMZN   3,582.18 (+2.21%)
TSLA   1,132.99 (+4.72%)
NVDA   328.41 (+4.25%)
BABA   131.76 (-1.19%)
NIO   40.01 (+0.05%)
CGC   11.02 (-5.73%)
AMD   158.89 (+2.64%)
GE   97.51 (-0.34%)
MU   84.79 (+1.64%)
T   23.88 (-1.40%)
F   19.73 (-0.10%)
DIS   144.95 (-2.13%)
ACB   6.43 (-5.30%)
AMC   36.47 (-3.08%)
PFE   53.77 (-0.43%)
BA   196.50 (-1.36%)
NYSE:CVS

CVS Health Price Target, Predictions & Analyst Ratings

$91.97
+0.45 (+0.49%)
(As of 11/29/2021 11:57 AM ET)
Add
Compare
Today's Range
$91.09
$92.35
50-Day Range
$83.15
$96.34
52-Week Range
$67.06
$96.57
Volume
130,054 shs
Average Volume
6.18 million shs
Market Capitalization
$121.41 billion
P/E Ratio
16.08
Dividend Yield
2.19%
Beta
0.81

CVS Health (NYSE:CVS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 18 Analyst Ratings

Analyst Price Target Consensus

$104.47
13.59% Upside

High PT$115.00
Average PT$104.47
Low PT$80.00
TypeCurrent
11/29/20 to 11/29/21
1 Month Ago
10/30/20 to 10/30/21
3 Months Ago
8/31/20 to 8/31/21
1 Year Ago
11/30/19 to 11/29/20
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$104.47$94.71$94.71$82.43
Price Target Upside13.59% Upside15.59% Upside15.48% Upside27.00% Upside
Get CVS Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CVS Health (NYSE:CVS) vs. Its Competitors

TypeCVS HealthRetail/Wholesale CompaniesS&P 500
Consensus Rating Score
2.83
2.51
2.56
Consensus RatingBuyBuyBuy
Price Target Upside13.59% Upside39.92% Upside11.47% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1334
77.69%
Underperform Votes
383
22.31%
Avg. Outperform Votes
421
66.09%
Avg. Underperform Votes
216
33.91%
Avg. Outperform Votes
834
69.50%
Avg. Underperform Votes
366
30.50%

CVS Health (NYSE:CVS) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/10/2021Mizuho
Boost Price TargetBuy$98.00 ➝ $105.00+13.20%
11/5/2021Deutsche Bank Aktiengesellschaft
George Hill
Boost Price TargetBuy$101.00 ➝ $107.00+11.92%
11/5/2021Credit Suisse Group
Boost Price TargetOutperform$100.00 ➝ $107.00+13.24%
11/5/2021JPMorgan Chase & Co.
Boost Price TargetBuy ➝ Overweight$107.00 ➝ $115.00+21.71%
11/4/2021Truist Securities
Boost Price TargetBuy$94.00 ➝ $112.00+18.56%
11/4/2021Royal Bank of Canada
Boost Price TargetOutperform$97.00 ➝ $107.00+11.06%
11/4/2021Raymond James
John Ransom
Boost Price TargetStrong-Buy$95.00 ➝ $115.00+19.37%
11/4/2021Citigroup
Boost Price TargetBuy$98.00 ➝ $111.00+15.22%
11/4/2021Barclays
Boost Price TargetOverweight$100.00 ➝ $110.00+14.18%
8/31/2021Morgan Stanley
Boost Price TargetTop Pick ➝ Overweight$99.00 ➝ $114.00+34.75%
7/23/2021Tigress Financial
Ivan Feinseth
Reiterated RatingBuy$108.00+29.70%
5/24/2021Wells Fargo & Company
Initiated CoverageEqual Weight$89.00-0.90%
5/19/2021BMO Capital Markets
Boost Price TargetPositive ➝ Market Perform$90.00 ➝ $96.00+8.34%
5/19/2021Wolfe Research
Boost Price TargetPositive ➝ Outperform$82.00 ➝ $93.00+4.95%
5/5/2021Jefferies Financial Group
Boost Price TargetBuy$90.00 ➝ $95.00+15.35%
3/23/2021Guggenheim
Reiterated RatingBuy ➝ Neutral
12/14/2020SVB Leerink
D. Ha
Boost Price TargetMarket Perform$73.00 ➝ $80.00+11.76%
11/11/2020Piper Sandler
Boost Price TargetOverweight$72.00 ➝ $76.00+8.22%
11/9/2020Cantor Fitzgerald
S. Halper
Reiterated RatingOverweight
5/7/2020Robert W. Baird
Boost Price TargetNeutral$62.00 ➝ $66.00+7.26%
5/7/2020UBS Group
Lower Price TargetBuy$85.00 ➝ $79.00+28.69%
5/6/2020Oppenheimer
Michael Wiederhorn
Reiterated RatingHold
4/13/2020SunTrust Banks
Lower Price TargetBuy$90.00 ➝ $80.00+32.30%
2/12/2020Cfra
Boost Price TargetStrong-Buy$85.00 ➝ $86.00+18.19%
10/21/2019Cowen
Charles Rhyee
Set Price TargetBuy$76.00+15.85%
9/12/2019Bank of America
Boost Price TargetBuy$72.00 ➝ $75.00+16.86%
8/7/2019Evercore ISI
Ross Muken
Set Price TargetBuy$63.00+6.71%
6/5/2019Standpoint Research
UpgradeHold ➝ Buy
4/15/2019CIBC
Reiterated RatingOutperform ➝ Market Perform
3/12/2019Sanford C. Bernstein
Initiated CoverageOutperform ➝ Outperform$76.00+39.07%
2/25/2019Argus
Lower Price TargetBuy ➝ Positive$100.00 ➝ $80.00+29.14%
2/21/2019Loop Capital
Andrew Wolf
Lower Price TargetIn-Line ➝ Hold$68.00+5.89%
11/29/2018The Goldman Sachs Group
Reiterated RatingNeutral ➝ Neutral$87.00+8.38%
(Data available from 11/29/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CVS Health (NYSE:CVS) Analyst Ratings Frequently Asked Questions

What is CVS Health's consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for CVS Health stock is Buy based on the current 4 hold ratings, 13 buy ratings and 1 strong buy rating for CVS. The average twelve-month price target for CVS Health is $104.47 with a high price target of $115.00 and a low price target of $80.00. Learn more on CVS's analyst rating history

Do Wall Street analysts like CVS Health more than its competitors?

Analysts like CVS Health stock more than the stock of other Retail/Wholesale companies. The consensus rating score for CVS Health is 2.83 while the average consensus rating score for retail/wholesale companies is 2.51. Learn more on how CVS compares to other companies

Do MarketBeat users like CVS Health more than its competitors?

MarketBeat users like CVS Health stock more than the stock of other Retail/Wholesale companies. 77.69% of MarketBeat users gave CVS Health an outperform vote while retail/wholesale companies recieve an average of 66.19% outperform votes by MarketBeat users.

Does CVS Health's stock price have much upside?

According to analysts, CVS Health's stock has a predicted upside of 15.25% based on their 12-month price targets.

This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.